What could cause a two‑day onset of aching, muscle‑growing sensation in the anterior thighs of a patient who started tadalafil (tadalafil) six days ago and otherwise feels fine?

Tadalafil-Associated Myalgia (Muscle Pain in Thighs)

This is almost certainly tadalafil-induced myalgia, a well-recognized adverse effect that typically manifests 12-24 hours after dosing and resolves within 2 days without intervention.

Clinical Presentation Matches Known Side Effect Profile

The patient's symptoms—aching sensation in the anterior thighs with a "growing" quality appearing on day 6 of tadalafil therapy—are consistent with the documented adverse effect profile of PDE5 inhibitors. Myalgia and back pain are among the most common side effects of tadalafil, occurring in approximately 8-9% of patients 1. The FDA label specifically notes that "men who get back pain and muscle aches usually get it 12 to 24 hours after taking tadalafil" and that "back pain and muscle aches usually go away within 2 days" 2.

Mechanism and Reassurance

The mechanism underlying tadalafil-associated myalgia remains incompletely understood, but extensive investigation has ruled out serious pathology. A dedicated three-part mechanistic study found no evidence of:

• Muscle inflammation or damage (normal laboratory markers)
• Renal injury
• Lumbar or gluteal myositis on PET or MRI imaging 3

These events are self-limiting and represent a general effect of PDE5 inhibition rather than tissue damage 3.

Management Algorithm

Immediate Assessment

• Confirm no other new medications or activities that could explain symptoms
• Verify no signs of rhabdomyolysis (severe pain, dark urine, weakness)
• Rule out deep vein thrombosis if unilateral leg involvement

Treatment Approach

1. Reassure the patient that this is a known, benign, self-limiting side effect
2. Symptomatic management:
   • First-line: Acetaminophen or NSAIDs (generally effective) 2
   • If inadequate relief: Mild narcotic (e.g., codeine) may be considered, though rarely necessary 2
3. Continue tadalafil if symptoms are tolerable—most patients do not discontinue (only 0.5-0.7% discontinue due to myalgia) 1, 2
4. Monitor for resolution within 2-3 days

If Symptoms Persist or Worsen

• Consider dose reduction (tadalafil shows dose-response pattern for adverse effects) 1
• Alternative: Switch to different PDE5 inhibitor—vardenafil and avanafil have lower myalgia rates than tadalafil 1

Key Clinical Pitfalls

Do not prematurely discontinue effective therapy. The vast majority of patients (>99%) continue treatment successfully despite transient myalgia 2. The symptoms typically diminish with continued use as tolerance develops.

Do not order extensive workup unless symptoms are severe, progressive, or atypical. The prospective study specifically demonstrated that inflammatory markers, muscle enzymes, and imaging are unrevealing 3.

Do not confuse this with serious adverse events. Unlike priapism, vision changes, or cardiovascular events, myalgia does not require emergency intervention or drug discontinuation 2.

Expected Timeline

Based on the FDA label and clinical trial data, expect:

• Onset: 12-24 hours post-dose (consistent with patient's day 6 presentation after multiple doses)
• Duration: Resolves within 2 days without treatment
• Severity: Typically mild to moderate 2

The patient's description of an aching, "growing" sensation is characteristic of the reported myalgia pattern and should resolve spontaneously with or without simple analgesics.